Target intelligence / Profile preview

TMEM252 divergent transcript (TMEM252-DT)

Target: TMEM252-DT
Molecular classification: Other

Overview

TMEM252 divergent transcript (TMEM252-DT) is a non-coding RNA transcript located near or overlapping the TMEM252 gene on human chromosome 9 (chr9:68539441-68644442, hg38). It is annotated in gene databases but has no recognized function, molecular activity, or druggability. TMEM252-DT should not be confused with TMEM252, a protein-coding gene whose protein product has possible tumor suppressor roles in certain cancers. There is no evidence supporting TMEM252-DT as a therapeutic target, a biomarker, a component of a disease pathway, or as having any functional biology distinct from its genomic location.

Biological functions

Other

Disease associations

Other

Beyond the preview

Go deeper on TMEM252 divergent transcript (TMEM252-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TMEM252 divergent transcript (TMEM252-DT).

Explore the full profile